跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,117 条关于
“Apnimed, Inc.”
全部
41,117
临床试验
11,398
药物
1,607
机构
6,174
资讯
21,938
上个月
Apnimed Closes Upsized $220.8 Million IPO to Advance Oral Therapy for Obstructive Sleep Apnea
去年
Apnimed's AD109 Phase 3 Trial for Obstructive Sleep Apnea Completes Enrollment
5个月前
Apnimed Secures $150M from Shionogi Joint Venture Sale, Advances First-in-Class OSA Drug Toward FDA Submission
8个月前
Apnimed Prepares FDA Filing for First-Ever Sleep Apnea Pill Following Successful Phase 3 Trials
10个月前
Apnimed's Sulthiame Shows Promise in Phase 2 Trial for Obstructive Sleep Apnea, Results Published in The Lancet
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
去年
IDEAYA Biosciences, Inc. (IDYA) BCG Matrix Analysis 2024
2年前
Immix Biopharma's NXC-201 Shows Promise as Outpatient CAR-T Therapy in Amyloidosis and Multiple Myeloma
第 1 页,共 2194 页
上一页
下一页